Tianda Pharmaceuticals Limited (HKG:0455)

Hong Kong · Delayed Price · Currency is HKD

0.0890

0.00 (0.00%)

At close: Oct 30, 2026

Market Cap	191.35M -34.6%
Revenue (ttm)	350.53M +12.9%
Net Income	-69.01M
EPS	-0.03
Shares Out	2.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0890
Day's Range	n/a
52-Week Range	0.0810 - 0.1360
Beta	-0.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine; Pharmaceuticals and Medical Technologies; and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products foc... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 573

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 0455

Full Company Profile

Financial Performance

In 2025, Tianda Pharmaceuticals's revenue was 322.95 million, a decrease of -2.12% compared to the previous year's 329.94 million. Losses were -70.00 million, 14.1% more than in 2024.

Financial Statements